Cite
HARVARD Citation
Shakya, S. et al. (n.d.). BIOM-22. BMX EXPRESSION LEVEL IN GLIOBLASTOMA PREDICTS HYPERSENSITIVITY TO IBRUTINIB TREATMENT. Neuro-oncology. pp. vii8-vii9. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shakya, S. et al. (n.d.). BIOM-22. BMX EXPRESSION LEVEL IN GLIOBLASTOMA PREDICTS HYPERSENSITIVITY TO IBRUTINIB TREATMENT. Neuro-oncology. pp. vii8-vii9. [Online].